Zobrazeno 1 - 10 of 16 pro vyhledávání: '"C P, Perlia"'
1
Adriamycin and Cytoxan in the treatment of inoperable lung cancer
Autor: T M, Hoeltgen, J M, MacIntyre, C P, Perlia, S W, Lagakos, L L, Stolbach, J M, Bennett
Publikováno v: Cancer. 51(11)
The results of a clinical trial involving 599 patients with inoperable squamous cell, large cell anaplastic, and adenocarcinoma of the lung are summarized. Patients were randomized to initial therapy with Cytoxan (CTX) (cyclophosphamide), or to one o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f40ec4abdec8df70281d731658470b85
https://pubmed.ncbi.nlm.nih.gov/6301671
Zobrazit plný text záznamu
2
Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung
Autor: J H, Edmonson, S W, Lagakos, O S, Selawry, C P, Perlia, J M, Bennett, F M, Muggia, G, Wampler, H S, Brodovsky, J, Horton, J, Colsky, E G, Mansour, R, Creech, L, Stolbach, E M, Greenspan, M, Levitt, L, Israel, E Z, Ezdinli, P P, Carbone
Publikováno v: Cancer treatment reports. 60(7)
Two hundred and fifty-eight patients with small cell carcinoma and 185 patients with adenocarcinoma were centrally randomized to receive either cyclophosphamide (1000 mg/m2 every 3 weeks) iv or cyclophosphamide (700 mg/m2 every 3 weeks) iv plus CCNU
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ab220e1f3ec3f63faaec71315437e2ae
https://pubmed.ncbi.nlm.nih.gov/1009523
Zobrazit plný text záznamu
3
A randomized comparison of two dosage schedules of methyl CCNU: three-week versus six-week treatments
Autor: S G, Taylor, W D, DeWys, C P, Perlia, J, Wolter, R E, Slayton, L A, Kosova, J D, Khandekar
Publikováno v: Cancer. 44(3)
Two dose schedules of methyl CCNU were compared for drug effect and toxicity. One hundred thirteen patients were stratified by tumor site, performance status, and prior chemotherapy and randomized to 100 mg/m2 q 3 wk or 200 mg/m2 q 6 wk orally. Respo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3a01e85933983043034ef6f77951619d
https://pubmed.ncbi.nlm.nih.gov/383272
Zobrazit plný text záznamu
6
Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in combination with cyclophosphamide (NSC-26271) in the treatment of human malignancies
Autor: I J, Piel, C P, Perlia
Publikováno v: Cancer chemotherapy reports. 59(5)
The effectiveness of cis-dichlorodiammineplatinum(II) in the treatment of human malignancies is evaluated. The first stage of our investigation consisted of a phase I study to determine toxicity. In the second stage attempts were made to reduce toxic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::43dac0199a50981cd22ec8b8505af936
https://pubmed.ncbi.nlm.nih.gov/1106849
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje